Our data show that NAT10 expression in tumor cells promotes PNI via the ac4C-ITGB5-pFAK-pSrc axis, highlighting the crucial role of ac4C modification in PNI, providing a therapeutic target for preventing PNI and improving the prognosis of patients with PDAC. This evidence concerns the gene ITGB5 and neoplasm.